Life sciences

Healthcare Life Sciences Solutions

Maintaining and enhancing productivity and compliance

In a market sensitive to power fluctuations, reducing operating risk is critical. Optimizing performance means you need to get to market faster and comply with regulations, while guaranteeing product and safety quality. Eaton innovations help ensure continuous uptime while safeguarding against power loss in the mission-critical manufacturing process. We also help control critical motor and HVAC loads while illuminating clean rooms with dust-free luminaires.

Energizing life science facilities to focus on their mission

For many life science organizations, keeping power up and running means you can continue to develop life-saving medications and maintain safety while your staff works. Eaton helps you ensure continuous uptime and maintain product integrity by safeguarding against loss of power in the mission-critical manufacturing process, protecting your scientific advances and your time to market.

Eaton can help you:

  • Comply with strict governmental regulations by providing your research and development facilities with active energy management solutions for efficient fan control
  • Outfit your facility with filtration systems for use in early diagnosis, prevention and therapy of various diseases
  • Ensure uninterrupted uptime and productivity in your facility, so you can continue to make important advancements in drug discovery
Featured case study

UPS yields perfect result for lab environment


Array relies on a variety of sensitive equipment to test and develop new medications. An unstable power event damaged a sensitive device, taking it out of commission for weeks.


Thanks to the deployment of the Eaton 9355 UPS, Array is now able to stay focused on the development of potentially life-saving drugs, rather than worrying about the uptime of its critical testing system.


15 kVA Eaton 9355 UPS


"The best part about the UPS is that I don't have to think about it. It's a watchdog we don't have to feed."
David Fry, Research Associate